Literature DB >> 2309816

Proteinuria and outcome of 444 pregnancies complicated by hypertension.

S Ferrazzani1, A Caruso, S De Carolis, I V Martino, S Mancuso.   

Abstract

The purpose of this study was to determine the role of proteinuria on pregnancy outcome in 444 hypertensive women with singleton pregnancies. The patients were divided into three hypertensive groups: 98 with chronic hypertension, 199 with nonproteinuric gestational hypertension, and 147 with proteinuric preeclampsia and chronic hypertension with superimposed proteinuric preeclampsia. The presence of increased proteinuria (greater than 0.3 gm/L) predicted an adverse pregnancy outcome. Furthermore, the majority of small-for-gestational-age infants occurred in the group with proteinuric preeclampsia (52%), whereas the rate of small-for-gestational-age infants was 18% and 12% in the group with nonproteinuric gestational hypertension and chronic hypertension, respectively. The group with chronic hypertension did not show any increased risk for fetal outcome. Perinatal mortality rate was extremely poor in the group with proteinuric preeclampsia at 129 per 1000, four times higher than those of the other two groups.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309816     DOI: 10.1016/0002-9378(90)90387-m

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community.

Authors:  Fiona Milne; Chris Redman; James Walker; Philip Baker; Julian Bradley; Carol Cooper; Michael de Swiet; Gillian Fletcher; Mervi Jokinen; Deirdre Murphy; Catherine Nelson-Piercy; Vicky Osgood; Stephen Robson; Andrew Shennan; Angela Tuffnell; Sara Twaddle; Jason Waugh
Journal:  BMJ       Date:  2005-03-12

Review 2.  Best practice in primary care pathology: review 10.

Authors:  W S A Smellie; N Shaw; R Bowley; M F Stewart; A M Kelly; P J Twomey; P R Chadwick; J B Houghton; J P Ng; A J McCulloch
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

3.  Assessment of proteinuria in pregnancy.

Authors:  Lucy C Chappell; Andrew H Shennan
Journal:  BMJ       Date:  2008-04-10

4.  Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction.

Authors:  Joanna L Stanley; Irene J Andersson; Cassandra J Hirt; Linn Moore; Mark R Dilworth; Alejandro R Chade; Colin P Sibley; Sandra T Davidge; Philip N Baker
Journal:  Biol Reprod       Date:  2012-07-26       Impact factor: 4.285

Review 5.  Treating hypertension in women of child-bearing age and during pregnancy.

Authors:  L A Magee
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia.

Authors:  Irina A Buhimschi; Guomao Zhao; Edmund F Funai; Nathan Harris; Isaac E Sasson; Ira M Bernstein; George R Saade; Catalin S Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2008-11       Impact factor: 8.661

Review 7.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review.

Authors:  Anne-Marie Côté; Mark A Brown; Elaine Lam; Peter von Dadelszen; Tabassum Firoz; Robert M Liston; Laura A Magee
Journal:  BMJ       Date:  2008-04-10

Review 8.  Control of hypertension in pregnancy.

Authors:  Laura A Magee; Edgardo Abalos; Peter von Dadelszen; Baha Sibai; Stephen A Walkinshaw
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

9.  Placental Pathology and Blood Pressure's Level in Women with Hypertensive Disorders in Pregnancy.

Authors:  Vassiliki Krielessi; Nikos Papantoniou; Ioannis Papageorgiou; Ioannis Chatzipapas; Efstathios Manios; Nikos Zakopoulos; Aris Antsaklis
Journal:  Obstet Gynecol Int       Date:  2012-05-07

Review 10.  Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review.

Authors:  Shakila Thangaratinam; Arri Coomarasamy; Fidelma O'Mahony; Steve Sharp; Javier Zamora; Khalid S Khan; Khaled M K Ismail
Journal:  BMC Med       Date:  2009-03-24       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.